1. Home
  2. VRDN vs BBN Comparison

VRDN vs BBN Comparison

Compare VRDN & BBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRDN
  • BBN
  • Stock Information
  • Founded
  • VRDN 2006
  • BBN 1983
  • Country
  • VRDN United States
  • BBN United States
  • Employees
  • VRDN N/A
  • BBN N/A
  • Industry
  • VRDN Medical Specialities
  • BBN Finance Companies
  • Sector
  • VRDN Health Care
  • BBN Finance
  • Exchange
  • VRDN Nasdaq
  • BBN Nasdaq
  • Market Cap
  • VRDN 1.3B
  • BBN 968.9M
  • IPO Year
  • VRDN N/A
  • BBN N/A
  • Fundamental
  • Price
  • VRDN $15.07
  • BBN $16.07
  • Analyst Decision
  • VRDN Strong Buy
  • BBN
  • Analyst Count
  • VRDN 11
  • BBN 0
  • Target Price
  • VRDN $38.50
  • BBN N/A
  • AVG Volume (30 Days)
  • VRDN 728.3K
  • BBN 231.8K
  • Earning Date
  • VRDN 08-07-2025
  • BBN 01-01-0001
  • Dividend Yield
  • VRDN N/A
  • BBN 6.90%
  • EPS Growth
  • VRDN N/A
  • BBN N/A
  • EPS
  • VRDN N/A
  • BBN N/A
  • Revenue
  • VRDN $302,000.00
  • BBN N/A
  • Revenue This Year
  • VRDN N/A
  • BBN N/A
  • Revenue Next Year
  • VRDN $17,102.33
  • BBN N/A
  • P/E Ratio
  • VRDN N/A
  • BBN N/A
  • Revenue Growth
  • VRDN 4.86
  • BBN N/A
  • 52 Week Low
  • VRDN $9.90
  • BBN $14.33
  • 52 Week High
  • VRDN $27.20
  • BBN $18.36
  • Technical
  • Relative Strength Index (RSI)
  • VRDN 61.91
  • BBN 59.19
  • Support Level
  • VRDN $13.84
  • BBN $15.90
  • Resistance Level
  • VRDN $14.85
  • BBN $16.20
  • Average True Range (ATR)
  • VRDN 0.82
  • BBN 0.15
  • MACD
  • VRDN -0.03
  • BBN 0.04
  • Stochastic Oscillator
  • VRDN 82.81
  • BBN 79.03

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).

About BBN BlackRock Taxable Municipal Bond Trust of Beneficial Interest

BlackRock Taxable Municipal Bond Trust is a diversified, closed-end management investment company. Its investment objective is to seek high current income, with a secondary objective of capital appreciation.

Share on Social Networks: